NO890174L - Rekombinante interleukin-1alfa-polypeptider. - Google Patents

Rekombinante interleukin-1alfa-polypeptider.

Info

Publication number
NO890174L
NO890174L NO89890174A NO890174A NO890174L NO 890174 L NO890174 L NO 890174L NO 89890174 A NO89890174 A NO 89890174A NO 890174 A NO890174 A NO 890174A NO 890174 L NO890174 L NO 890174L
Authority
NO
Norway
Prior art keywords
polypeptides
1alfa
dna sequences
recombinant interleukin
recombinant vectors
Prior art date
Application number
NO89890174A
Other languages
English (en)
Other versions
NO890174D0 (no
Inventor
Peter T Lomedico
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO890174D0 publication Critical patent/NO890174D0/no
Publication of NO890174L publication Critical patent/NO890174L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/54Interleukins [IL]
    • C07K14/545IL-1
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Homogene rekombinante huaane intarleukin-lo polypep- tider, DNA-sekvenser som koder for slike polypeptider, rekonbinante vektorer inneholdende DNA-sekvenser, én- cellede vertsorganismer inneholdende slike rekonbinante vektorer, samt fremgangsmåter for fremstilling av polypeptidene. De humane interleukin-loc polypeptider og farmasøytiske blandinger inneholdende disse kan bli brukt for a stimulere immunsystemet hos en vert for å fremme sårleging og for a forbedre legingen av kritisk syke protein-undererruerte pasienter.
NO89890174A 1988-01-15 1989-01-13 Rekombinante interleukin-1alfa-polypeptider. NO890174L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14445788A 1988-01-15 1988-01-15

Publications (2)

Publication Number Publication Date
NO890174D0 NO890174D0 (no) 1989-01-13
NO890174L true NO890174L (no) 1989-07-17

Family

ID=22508674

Family Applications (1)

Application Number Title Priority Date Filing Date
NO89890174A NO890174L (no) 1988-01-15 1989-01-13 Rekombinante interleukin-1alfa-polypeptider.

Country Status (19)

Country Link
EP (1) EP0324447B1 (no)
JP (1) JP2567079B2 (no)
AR (1) AR245958A1 (no)
AT (1) ATE142696T1 (no)
AU (1) AU616461B2 (no)
DE (1) DE58909723D1 (no)
DK (1) DK16489A (no)
ES (1) ES2091752T3 (no)
FI (1) FI890175A (no)
GR (1) GR3021887T3 (no)
HU (1) HU208996B (no)
IE (1) IE890087L (no)
IL (1) IL88934A (no)
MC (1) MC2002A1 (no)
NO (1) NO890174L (no)
NZ (1) NZ227594A (no)
PT (1) PT89438B (no)
YU (1) YU6889A (no)
ZA (1) ZA89202B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3587605T2 (de) * 1984-12-25 1994-03-17 Dainippon Pharmaceutical Co Interleukin-1 und dessen Derivat.
DE3818660A1 (de) * 1987-06-05 1988-12-15 Colgate Palmolive Co Freifliessendes, pulvriges geschirrwaschmittel und verfahren zur herstellung desselben
US5120534A (en) * 1988-07-29 1992-06-09 Otsuka Pharmaceutical Co., Ltd. IL-1α derivatives and medicament for treating thrombocytopenia
US6191269B1 (en) 1997-05-30 2001-02-20 The Regents Of The University Of California Selective induction of cell death by delivery of amino-terminal interleukin-1-α pro-piece polypeptide
US7176179B1 (en) 1997-05-30 2007-02-13 The Regents Of The University Of California Selective induction of cell death by delivery of amino-terminal interleukin-1-α pro-piece polypeptide
US20030154504A1 (en) 1998-06-24 2003-08-14 Farese Robert V. Methods and compositions for modulating carbohydrate metabolism
DE10252634A1 (de) * 2002-11-11 2004-05-27 Umwelttechnik Georg Fritzmeier Gmbh & Co. Reinigungsmittel und Verfahren zu seiner Herstellung
BR112012007399A2 (pt) * 2009-09-29 2016-08-09 United Technologies Ut Ag composição de cuidado oral, usos da interleucina-1 recombinante humana e métodos para reduzir o mau hálito e para o tratamento ou prevenção de doença periodontal.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3587605T2 (de) * 1984-12-25 1994-03-17 Dainippon Pharmaceutical Co Interleukin-1 und dessen Derivat.
EP0200986B2 (en) * 1985-04-25 1998-03-11 F. Hoffmann-La Roche Ag Recombinant human interleukin-1
DE3515217A1 (de) * 1985-04-26 1986-10-30 Siemens AG, 1000 Berlin und 8000 München Vorrichtung zur messung schwacher magnetfelder
US5017692A (en) * 1986-09-04 1991-05-21 Schering Corporation Truncated human interleukin-a alpha

Also Published As

Publication number Publication date
PT89438A (pt) 1990-02-08
JPH025892A (ja) 1990-01-10
ATE142696T1 (de) 1996-09-15
HU208996B (en) 1994-09-28
DE58909723D1 (de) 1996-10-17
FI890175A0 (fi) 1989-01-13
IL88934A0 (en) 1989-08-15
EP0324447A2 (de) 1989-07-19
AR245958A1 (es) 1994-03-30
GR3021887T3 (en) 1997-03-31
NZ227594A (en) 1991-09-25
JP2567079B2 (ja) 1996-12-25
IL88934A (en) 1994-05-30
DK16489A (da) 1989-07-16
AU616461B2 (en) 1991-10-31
HUT50505A (en) 1990-02-28
FI890175A (fi) 1989-07-16
YU6889A (en) 1990-08-31
ES2091752T3 (es) 1996-11-16
AU2850989A (en) 1989-07-20
MC2002A1 (fr) 1990-01-26
IE890087L (en) 1989-07-15
ZA89202B (en) 1989-09-27
NO890174D0 (no) 1989-01-13
EP0324447A3 (de) 1990-01-31
PT89438B (pt) 1993-09-30
DK16489D0 (da) 1989-01-13
EP0324447B1 (de) 1996-09-11

Similar Documents

Publication Publication Date Title
NZ223506A (en) Tissue factor protein, dna encoding it, vectors, host cells, production of the protein and pharmaceutical compositions
DK0751992T3 (da) Karendotelvækstfaktor 2
DE69428214D1 (de) Transformierender wachstumsfaktor alpha h1
ZA91134B (en) New proteins produced by human lymphocytes,dna sequence encoding these proteins and their pharmaceutical and biological uses
IL99401A0 (en) Nucleotide sequence coding for an outer membrane protein and use of said protein in vaccine preparations
DE69630890D1 (de) Peptid-immitierende substanzen in der krebstherapie
NZ504026A (en) Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C
DE68929551D1 (de) Menschliche DNase
NO177678C (no) Fremgangsmåte for fremstilling av et terapeutisk aktivt, rekombinant protein som har ASP-aktivitet, ekspresjonssystem samt DNA som koder for nevnte protein
AU1724795A (en) Human tissue inhibitor of metalloproteinase-4
DE3682229D1 (de) Zur stimulierung der traenensekretion verwendbare pharmazeutische praeparate.
ZA87141B (en) Dna sequences coding for proteins having the biological activity of husi-type i inhibitors,biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins
NO890174L (no) Rekombinante interleukin-1alfa-polypeptider.
IL87391A0 (en) Hiv proteins and peptides,dna coding therefor,vectors comprising such dna,the use of the proteins and peptides in diagnosis of aids and vaccine compositions containing them
AU1987088A (en) A process for preparing a protein or polypeptide, a dna sequence coding for the polypeptide, a microorganism containing the dna sequence as well as the polypeptide and its use as a pharmaceutical preparation
DK288789A (da) Peptider og syreadditionssalte deraf, deres fremstilling og anvendelse
ZA904565B (en) Peptides and antibodies derived therefrom for the diagnosis of therapy for and vaccination against htlv-1 infection
LV11803A (lv) Nesplaisinga gp350/220 varianti
AU2459188A (en) Anticoagulative protein pp4-x, and its preparation and use
SG128403A1 (en) Tnf-receptors, tnf binding proteins and dnas coding for them
DK0555785T3 (da) Glat-muskel-mitogent stof og DNA, der koder herfor
ATE6639T1 (de) Ein gereinigtes polypeptid, ein verfahren zu dessen herstellung, dessen anwendung und das enthaltende pharmazeutische praeparat.
DK575287A (da) Anvendelse af vaevsfaktorprotein og antagonister herfor til fremstilling af laegemidler til behandling af bloedningsforstyrrelser samt farmaceutiske praeparater indeholdende disse